Network pharmacology combined with ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry method to explore the mechanism of Shizhi Fang in treating uric acid nephropathy mice. [PDF]
J Tradit Chin MedFeng Y +3 more
europepmc +1 more source
Exploring the role of febuxostat's drug target XOR in erectile dysfunction: insights from human genetics and rat models. [PDF]
Front Med (Lausanne)Chen Z +9 more
europepmc +1 more source
Switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, may substantially reduce serum urate levels, through URAT1 inhibition, potentially without adversely affecting ABCG2 function: findings from the SWITCH SURI study. [PDF]
Front Endocrinol (Lausanne)Osonoi T +7 more
europepmc +1 more source
A novel and two recurrent UMOD mutations in autosomal dominant tubulointerstitial kidney disease (ADTKD): a case series and literature review. [PDF]
Ren FailYu Y +5 more
europepmc +1 more source
Dual-drug nanocarriers for gout therapy: targeted co-delivery of anti-inflammatory and urate-lowering agents: a review. [PDF]
EXCLI JKarusan NR +6 more
europepmc +1 more source
The efficacy and safety of different doses of febuxostat and allopurinol: A meta-analysis. [PDF]
Jt Dis Relat SurgZhang F, Wang Y.
europepmc +1 more source
Spontaneous rupture of a normal spleen successfully treated with elective laparoscopic splenectomy: a case report. [PDF]
J Surg Case RepSakamoto R +4 more
europepmc +1 more source
Comparative risk of retinal microvascular disorders in patients with gout initiating febuxostat versus allopurinol: a population-based cohort study. [PDF]
Sci RepKim MJ +8 more
europepmc +1 more source